Association between plaque vulnerability and neutrophil extracellular traps (NETs) levels: The Plaque At RISK study

PLoS One. 2022 Jun 9;17(6):e0269805. doi: 10.1371/journal.pone.0269805. eCollection 2022.

Abstract

Carotid atherosclerotic plaque rupture and its sequelae are among the leading causes of acute ischemic stroke. The risk of rupture and subsequent thrombosis is, among others, determined by vulnerable plaque characteristics and linked to activation of the immune system, in which neutrophil extracellular traps (NETs) potentially play a role. The aim of this study was to investigate how plaque vulnerability is associated with NETs levels. We included 182 patients from the Plaque At RISK (PARISK) study in whom carotid imaging was performed to measure plaque ulceration, fibrous cap integrity, intraplaque hemorrhage, lipid-rich necrotic core, calcifications and plaque volume. Principal component analysis generated a 'vulnerability index' comprising all plaque characteristics. Levels of the NETs marker myeloperoxidase-DNA complex were measured in patient plasma. The association between the vulnerability index and low or high NETs levels (dependent variable) was assessed by logistic regression. No significant association between the vulnerability index and NETs levels was detected in the total population (odds ratio 1.28, 95% confidence interval 0.90-1.83, p = 0.18). However, in the subgroup of patients naive to statins or antithrombotic medication prior to the index event, this association was statistically significant (odds ratio 2.08, 95% confidence interval 1.04-4.17, p = 0.04). Further analyses revealed that this positive association was mainly driven by intraplaque hemorrhage, lipid-rich necrotic core and ulceration. In conclusion, plaque vulnerability is positively associated with plasma levels of NETs, but only in patients naive to statins or antithrombotic medication prior to the index event.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carotid Arteries
  • Carotid Stenosis* / complications
  • Extracellular Traps*
  • Fibrinolytic Agents
  • Hemorrhage / etiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Ischemic Stroke*
  • Lipids
  • Magnetic Resonance Imaging / methods
  • Necrosis
  • Plaque, Atherosclerotic* / complications
  • Risk Factors
  • Stroke* / complications

Substances

  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids

Grants and funding

This work was supported by the Centre for Translational Molecular Medicine (www.ctmm.nl) [project PARISK (Plaque at RISK); grant 01C-202]; the Dutch Heart Foundation (www.hartstichting.nl), the Trombose stichting (www.trombosestichting.nl) [TSN2013-2]; and the European Union’s Horizon 2020 – Research and Innovation Framework Programme (https://ec.europa.eu/programmes/horizon2020/) [Marie Skłodowska-Curie grant agreement No 722609]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.